October 15, 2025 · Form 4 insider transaction
Kelly Thomas Patrick bought 30,000 shares of XENON PHARMACEUTICALS INC at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on October 15, 2026.